Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hutchmed (HCM) Share News

12345678910

EARNINGS REPORTS: Elementis swings to profit; Hutchmed changes CEO

3rd Mar 2022 13:02

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

TRADING UPDATES: Hutchmed in Macau boost; UP Global success in Germany

1st Mar 2022 20:32

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK earnings, trading statements calendar - next 7 days

24th Feb 2022 15:54

Read More

Hutchmed starts new phase of probe on HMPL-453 as combination therapy

4th Feb 2022 10:36

Hutchmed starts new phase of probe on HMPL-453 as combination therapy Read More

Hutchmed begins phase one study for potential tumour treatment

20th Jan 2022 11:03

Hutchmed begins phase one study for potential tumour treatment Read More

TOP NEWS: Retailer ASOS now to be seen on London Main Market

13th Jan 2022 09:10

TOP NEWS: Retailer ASOS now to be seen on London Main Market Read More

Hutchmed gains breakthrough therapy designation in China for HMPL-523

12th Jan 2022 11:37

Hutchmed gains breakthrough therapy designation in China for HMPL-523 Read More

Hutchmed begins phase one study for potential cancer treatment

10th Jan 2022 09:23

Hutchmed begins phase one study for potential cancer treatment Read More

Hutchmed completes patient enrolment for cancer drug study

6th Dec 2021 10:44

Hutchmed completes patient enrolment for cancer drug study Read More

Two Hutchmed drugs included on China's state approved medicines list

3rd Dec 2021 09:54

Two Hutchmed drugs included on China's state approved medicines list Read More

Hutchmed China shares rise on Orphathys and Tagrisso Phase 3 study

24th Nov 2021 11:35

Hutchmed China shares rise on Orphathys and Tagrisso Phase 3 study Read More

TOP NEWS: Astra transfers drug rights to Covis in USD270 million deal

1st Nov 2021 09:14

TOP NEWS: Astra transfers drug rights to Covis in USD270 million deal Read More

IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug

28th Oct 2021 21:59

IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug Read More

Hutchmed China sells joint venture stake for USD169 million

29th Sep 2021 11:08

Hutchmed China sells joint venture stake for USD169 million Read More

Hutchmed starts drug combination trial for neuroendocrine tumours

21st Sep 2021 10:51

Hutchmed starts drug combination trial for neuroendocrine tumours Read More

Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors

20th Sep 2021 09:09

Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors Read More

Hutchmed China's amdizalisib secures breakthrough therapy designation

13th Sep 2021 10:22

Hutchmed China's amdizalisib secures breakthrough therapy designation Read More

Hutchmed, Astra launch drug combination trial to treat lung cancer

8th Sep 2021 13:49

Hutchmed, Astra launch drug combination trial to treat lung cancer Read More

Hutchmed China to trade in Shanghai and Shenzhen through link scheme

6th Sep 2021 09:37

Hutchmed China to trade in Shanghai and Shenzhen through link scheme Read More

Hutchmed launches trial into drug combination to treat breast cancer

26th Aug 2021 10:38

Hutchmed launches trial into drug combination to treat breast cancer Read More

12345678910
FTSE 100 Latest
Value8,774.65
Change-17.15